rs55928386

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000648167.1(HTRA1):​c.154+2442C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.131 in 152,204 control chromosomes in the GnomAD database, including 1,811 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1811 hom., cov: 34)

Consequence

HTRA1
ENST00000648167.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.79

Publications

9 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.245 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000648167.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HTRA1
ENST00000648167.1
c.154+2442C>T
intron
N/AENSP00000498033.1A0A3B3IU24
HTRA1-AS1
ENST00000650300.1
n.233G>A
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19950
AN:
152096
Hom.:
1807
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.249
Gnomad AMI
AF:
0.0822
Gnomad AMR
AF:
0.0876
Gnomad ASJ
AF:
0.0282
Gnomad EAS
AF:
0.0745
Gnomad SAS
AF:
0.0776
Gnomad FIN
AF:
0.0537
Gnomad MID
AF:
0.0828
Gnomad NFE
AF:
0.0958
Gnomad OTH
AF:
0.119
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.131
AC:
19969
AN:
152204
Hom.:
1811
Cov.:
34
AF XY:
0.128
AC XY:
9549
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.249
AC:
10342
AN:
41556
American (AMR)
AF:
0.0875
AC:
1338
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0282
AC:
98
AN:
3470
East Asian (EAS)
AF:
0.0744
AC:
383
AN:
5150
South Asian (SAS)
AF:
0.0771
AC:
372
AN:
4828
European-Finnish (FIN)
AF:
0.0537
AC:
570
AN:
10612
Middle Eastern (MID)
AF:
0.0822
AC:
24
AN:
292
European-Non Finnish (NFE)
AF:
0.0958
AC:
6514
AN:
67970
Other (OTH)
AF:
0.120
AC:
253
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
863
1727
2590
3454
4317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.110
Hom.:
154
Bravo
AF:
0.139
Asia WGS
AF:
0.100
AC:
348
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.0
DANN
Benign
0.85
PhyloP100
-2.8
PromoterAI
0.00060
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs55928386;
hg19: chr10-124220667;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.